Thursday, April 08, 2010 10:38:33 PM
FDA BIOD Oct 30, 2010
Biodel (BIOD)
Drug/indication: VIAject for diabetes
Approval decision date: Oct. 30
VIAject is a fast-acting insulin analogue designed for absorption into the bloodstream that's faster than currently marketed rapid-acting insulins.
Biodel (BIOD)
Drug/indication: VIAject for diabetes
Approval decision date: Oct. 30
VIAject is a fast-acting insulin analogue designed for absorption into the bloodstream that's faster than currently marketed rapid-acting insulins.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
